logo
A-ha singer Morten Harket has Parkinson's disease

A-ha singer Morten Harket has Parkinson's disease

Yahoo3 days ago

The lead singer of A-ha has revealed he has been diagnosed with Parkinson's disease.
Morten Harket, the Norwegian synth-pop band's frontman, released a statement on Wednesday about his diagnosis of the progressive neurological disorder and its effect on his career.
The Take On Me singer, 65, admitted he was 'uncertain' about his future as a vocalist as he was 'trying the best I can to prevent my entire system from going into decline'.
Harket, a father of five, underwent several rounds of brain surgery last year to manage his physical symptoms of the condition.
A lengthy statement published on the band's website on Wednesday, written by their biographer, read: 'In recent years, Morten Harket has also been a man battling his own body.
'This isn't the sort of news anyone wants to deliver to the world, but here it is: Morten has Parkinson's disease.'
Harket told the biographer Jan Omdahl that he had wanted to reveal his condition to fans earlier, but that his need for 'peace and quiet to work has been stopping me'.
He added that 'problems with my voice are one of many grounds for uncertainty about my creative future'.
Symptoms of Parkinson's, which is the fastest-growing neurological condition in the world, include tremor, slowness of movement and muscle rigidity.
It is caused by the death of nerve cells in the brain that produce the neurotransmitter dopamine. About 153,000 people in the UK have Parkinson's, but cases are predicted to rise to 172,000 by 2030 as the population ages.
'It's a difficult balancing act between taking the medication and managing its side effects,' Harket explained.
'There's so much to weigh up when you're emulating the masterful way the body handles every complex movement, or social matters and invitations, or day-to-day life in general.'
The brand's frontman, who has been performing since the 1980s, said that at the moment, he did not 'feel like singing', explaining that 'for me, that's a sign'.
He added: 'I'm broad-minded in terms of what I think works; I don't expect to be able to achieve full technical control.
'The question is whether I can express myself with my voice. As things stand now, that's out of the question. But I don't know whether I'll be able to manage it at some point in the future.'
Harket said he had 'taken to heart my 94-year-old father's attitude to the way the organism gradually surrenders: 'I use whatever works''.
However, the musician has been making use of advanced technology in treating the disease, including using a method called deep brain stimulation (DBS).
The neurosurgical procedure, which he had done in June and December last year, included implanting electrodes into the two sides of his brain.
A-ha's biographer wrote that these surgeries 'led to a dramatic improvement in his symptoms'.
'The procedure had the desired effect: with the right electrical impulses now reaching Morten's brain, many of his physical symptoms practically vanished,' Mr Omdahl added.
Harket's neurologist in Norway, Dr Christina Sundal, was previously a research fellow with the Parkinson's team at the Mayo Clinic.
Mr Omdahl, who observed the lead singer at his summer home in Norway, described the symptoms as a 'never-ending roller-coaster ride'.
Discussing his future as A-ha's vocalist, Harket said he 'can't answer' whether his voice is the best he could hope for following the DBS treatments.
The vocalist, who is known for his unique singing voice and technique, explained: 'When we tune the frequencies and direction of the electrodes, it is also able to affect the region of the voice, but we're not yet able to capture and control it.
'The voice problem comes especially when I take dopamine supplements. If I don't take dopamine, my voice settles down – but then the general underlying symptoms become more pronounced.'
The band, which was formed in Oslo in 1982, comprises guitarist Paul Waaktaar-Savoy, keyboardist Magne Furuholmen and lead singer Harket.
A-ha have had nine top 10 singles in the UK chart, including the chart-topping track The Sun Always Shines on TV, and seven top 10 albums.
Furuholmen said in an Instagram post on Wednesday: 'It is a day of sad news in A-ha world. Having known about Morten's diagnosis for some time does not take the force out of the blow, nor diminish the impact it has had, and will continue to have, on us – as people and as a band.
'Our thoughts are first and foremost with Morten and his family at a difficult time adjusting to the changes that this condition has brought into their lives.
'As the news brings sadness, it is worth to remember through the hurt that there is also a lot of gratitude: for all the amazing memories, for how our combined creative efforts as a band have been so generously embraced by the world, and for how lucky we are that people continue to find meaning, hope and joy in our shared musical legacy.
'All future A-ha-related activities will, of course, be tuned to suit Morten's situation, but together we will work to try and find ways to give you the best of ourselves. Thank you, everyone, for all your support, your kind words and consideration.'
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

BrainDefender Research Announces Launch of New Cognitive Support Formula for Adults
BrainDefender Research Announces Launch of New Cognitive Support Formula for Adults

Business Upturn

time7 hours ago

  • Business Upturn

BrainDefender Research Announces Launch of New Cognitive Support Formula for Adults

Denver, June 06, 2025 (GLOBE NEWSWIRE) — BrainDefender Research today announced the launch of BrainDefender Memory Support Supplement , a new cognitive wellness formula developed to support focus, mental clarity, and memory in adults. Manufactured in a GMP-certified facility in the United States, the product is designed for individuals seeking to maintain healthy cognitive function through natural, plant-based supplementation. The new formula features a combination of Ginkgo Biloba, Bacopa Monnieri, Huperzine-A, Phosphatidylserine, and N-Acetyl-L-Carnitine—ingredients that have each been individually studied for their potential roles in brain function. BrainDefender Research emphasizes that the supplement is intended for use as part of a wellness routine to support cognitive performance and healthy aging. 'Consumer interest in natural brain support has grown significantly in recent years,' said a spokesperson for BrainDefender Research. 'We developed this product to offer adults a well-rounded option for supporting mental clarity, focus, and memory performance using recognizable, research-supported ingredients.' The company recommends consistent daily use over a 90-day period for best results and offers a 60-day refund policy for customer satisfaction. The product is available for purchase in 30-day, 90-day, and 180-day supply options to accommodate individual wellness goals. Availability BrainDefender Memory Support Supplement can be ordered directly through the company's official website and is also offered via the ClickBank platform. Domestic orders are typically delivered within 5–7 business days, while international shipping may take 10–12 business days. About BrainDefender Research BrainDefender Research is a U.S.-based wellness company focused on the development of cognitive support supplements using plant-based ingredients. All products are manufactured in GMP-certified facilities to ensure quality and safety in every batch. Disclaimer These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individuals should consult a licensed healthcare provider before beginning any new supplement routine, especially if taking medications or managing a medical condition. Media Contact Email: [email protected] Phone: (855) 473-4405 Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.

USS Gettysburg returns to Naval Station Norfolk after 8-month deployment
USS Gettysburg returns to Naval Station Norfolk after 8-month deployment

Yahoo

time9 hours ago

  • Yahoo

USS Gettysburg returns to Naval Station Norfolk after 8-month deployment

NORFOLK, Va. (WAVY) – After an 8-month deployment, USS Gettysburg, part of the Harry S. Truman Carrier Strike Group, has returned to its homeport at Naval Station Norfolk. Bittersweet homecoming for USS Harry S. Truman The Ticonderoga class cruiser departed in September 2024, traveling to Europe and the Middle East to conduct combat operations in the Red Sea, as well as exercises with NATO allies. 'It was amazing in a lot of ways. We learned a lot. We have a lot to share with the fleet based off our experience in the Red Sea in particular, but the feeling to be home as well, it's amazing,' said Captain John Lucas, Commanding Officer of USS Gettysburg. Retired naval aviator shares insight on 'friendly fire' incident in the Red Sea The ship was in headlines back in December following an instance of friendly fire, shooting down a U.S. Navy F/A-18 Super Hornet over the Red Sea. 'It's under investigation, those results have not been revealed yet to the public. I can tell you again, we took on a lot of lessons from that event,' said Captain Lucas. After the deployment was extended twice, families of the roughly 330 returning sailors gathered along the pier at Naval Station Norfolk to welcome their loved ones home. 'It's a very long time. We're kind of used to it. We have another child in the military, so we've been down this road. But this is her first time having been gone so this long, so it was tough. We're going to take her home and whatever she wants to do is what she wants to do. It's her break, with us along for the ride,' said Carrie Ayd, mother of returning sailor. Captain Lucas said while the Navy is retiring certain cruisers, he's not certain what the future holds for USS Gettysburg, but said he and his crew will be ready when called upon. 'I think we're all ready for a nice long winter nap in the summer. All I can tell you is my job and this crew's job is going to be to be ready to go again when called upon, whenever that might be. I'm excited to maintain and be a part of the team for as long as they'll have me,' he said. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

BrainDefender Research Announces Launch of New Cognitive Support Formula for Adults
BrainDefender Research Announces Launch of New Cognitive Support Formula for Adults

Yahoo

time10 hours ago

  • Yahoo

BrainDefender Research Announces Launch of New Cognitive Support Formula for Adults

Plant-Based Supplement Includes Five Individual Ingredients Studied for Their Role in Supporting Memory and Focus Denver, June 06, 2025 (GLOBE NEWSWIRE) -- BrainDefender Research today announced the launch of , a new cognitive wellness formula developed to support focus, mental clarity, and memory in adults. Manufactured in a GMP-certified facility in the United States, the product is designed for individuals seeking to maintain healthy cognitive function through natural, plant-based supplementation. The new formula features a combination of Ginkgo Biloba, Bacopa Monnieri, Huperzine-A, Phosphatidylserine, and N-Acetyl-L-Carnitine—ingredients that have each been individually studied for their potential roles in brain function. BrainDefender Research emphasizes that the supplement is intended for use as part of a wellness routine to support cognitive performance and healthy aging. 'Consumer interest in natural brain support has grown significantly in recent years,' said a spokesperson for BrainDefender Research. 'We developed this product to offer adults a well-rounded option for supporting mental clarity, focus, and memory performance using recognizable, research-supported ingredients.' The company recommends consistent daily use over a 90-day period for best results and offers a 60-day refund policy for customer satisfaction. The product is available for purchase in 30-day, 90-day, and 180-day supply options to accommodate individual wellness goals. AvailabilityBrainDefender Memory Support Supplement can be ordered directly through the company's official website and is also offered via the ClickBank platform. Domestic orders are typically delivered within 5–7 business days, while international shipping may take 10–12 business days. About BrainDefender ResearchBrainDefender Research is a U.S.-based wellness company focused on the development of cognitive support supplements using plant-based ingredients. All products are manufactured in GMP-certified facilities to ensure quality and safety in every batch. DisclaimerThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individuals should consult a licensed healthcare provider before beginning any new supplement routine, especially if taking medications or managing a medical condition. Media Contact Email: support@ Phone: (855) 473-4405 CONTACT: Email: support@ Phone: (855) 473-4405Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store